Wellcome responds to WHO Europe and ECDC tuberculosis surveillance report

Ana Cehovin, Research Lead at Wellcome, said: 

“Tuberculosis remains a major global health threat across all settings. Europe is struggling with an intertwined issue of missing diagnoses and rising drug-resistance are two alarming factors that underscore the urgent need to improve our approach to TB prevention and treatment. We need rapid, accurate and accessible diagnostics, including identifying what drug combinations will be best to treat drug-resistant tuberculosis, and better understanding of how resistance emerges - which requires support and scale up from national and international leadership, private sector and funders.”